Marine Veteran & Managing Director, Connecticut Innovations
Russ has been an observing board member for C2C since December 2011. As a Marine Veteran and experienced engineer and investment professional, he brings a deep appreciation of military service and a wealth of industry expertise to the team.
Russell has invested in more than 50 companies during his tenure at CI. He has led CI’s investments in bioscience companies including Affomix Corporation, Cardiopulmonary Corporation, Genaissance Pharmaceuticals, Ipsogen and Metagenomix, Inc. Russell has also led CI’s investments in I-Mark and LiveClips, and serves on a number of boards. Seven of the current or former CI portfolio companies that Russell has worked with have had successful initial public offerings.
Russell has considerable experience in economic and venture analysis, engineering cost accounting, systems analysis, scientific and commercial programming, math analysis, EDP auditing and computer modeling.
He was previously with United Technologies Corp., Wolf Research and Development, Scientific Leasing and the Robert E. Nolan Co.
- B.S., Electrical Engineering, University of Hartford
- M.B.A., University of Hartford